| Financial Year |
March 31 2023 |
| Monetary Funds |
85,818,175.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,550,088.35 |
| Accounts Receivable |
524,341,232.33 |
| Advances to Suppliers |
116,364,078.27 |
| Other Receivables |
78,391,773.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
182,019,563.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,169,873.13 |
| Total Current Assets |
1,042,324,948.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
42,942,350.01 |
| Investment Properties |
-- |
| Fixed Assetes |
116,142,439.58 |
| Under-construction Projects |
10,007,196.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
54,896,387.25 |
| R&D expenses |
-- |
| Goodwill |
140,130,942.62 |
| Long-Term Deferred and Prepaid Expenses |
582,106.85 |
| Deferred Income Tax Assets |
32,901,159.50 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
415,183,582.33 |
| Total Assets |
1,457,508,530.84 |
| Short-Term Loans |
122,914,940.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
48,985,946.00 |
| Accounts Payable |
141,634,848.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,805,054.39 |
| Taxes Payable |
7,552,383.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,532,631.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,777,227.03 |
| Other Current Liabilities |
38,028,682.62 |
| Sub-Total of Current Liabilities |
570,461,808.46 |
| Long-term Loans |
10,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,518,205.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,274,297.91 |
| Total Liabilities |
600,736,106.37 |
| Paid-In Capital(Or Share Stock) |
535,529,908.00 |
| Capital Surplus |
523,364,322.60 |
| Surplus Reserve |
20,601,364.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-172,752,376.45 |
| Minority Stockholder's Interest |
-19,725,352.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
876,497,777.02 |
| Owner's Equity（Stockholder's Equity） |
856,772,424.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,457,508,530.84 |
